Chance Pharmaceuticals

About:

Chance Pharmaceuticals is a clinical-stage biotechnology company focusing on discovering.

Website: http://www.chancepharmaceuticals.com/

Top Investors: Fortune Venture Capital, Delian Capital, Shenzhen Guozhong Venture Capital Management, Kaitai Capital, Lapam Capital

Description:

Chance Pharmaceuticals provides, discovers, develops, and commercializes inhalation therapies for the world’s debilitating diseases such as chronic obstructive pulmonary disease, asthma, pulmonary arterial hypertension, and central nervous system disorders.

Total Funding Amount:

$51.3M

Headquarters Location:

Hangzhou, Zhejiang, China

Founded Date:

2015-01-01

Founders:

Donghao Chen, James Huang

Number of Employees:

1-10

Last Funding Date:

2022-01-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai